Dr. Jessica Lichter, Assistant Professor and academic hospitalist at Elmhurst Hospital, part of the New York City Health + ...

"Our research reveals the potential for digenic inheritance—where two genes work together to cause disease—expanding our ...

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that may contribute to congenital heart disease (CHD), a common birth defect.

Scientists at the Icahn School of Medicine at Mount Sinai and collaborators have identified novel genetic interactions that ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful computational tool, named iDOMO, to improve the prediction of ...

Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...

Researchers have developed a powerful computational tool, named iDOMO, to improve the prediction of drug synergy and accelerate the development of combination therapies for complex diseases. The study ...

After spending 28 years at Yale New Haven (Conn.) Health, Lisa Stump made a big decision last September. She joined Mount Sinai Health System in New York City as executive vice president and chief ...

The Manhasset SCA is currently accepting applications for the 2025 Summer Studies Program. The deadline for completed applications is by March 7.

A study at Mount Sinai has shown that children with a high tolerance for peanuts can significantly increase their resistance ...

Findings suggest a safe, inexpensive, and effective pathway for allergists to treat children who already tolerate at least half a peanut.

In the past, Dr. Horowitz had been a paid consultant for Purple Biotech.